Pediatrix Medical Group, Inc. (MD) Stock
MD Key Statistics
About Pediatrix Medical Group, Inc.
Pediatrix Medical Group, Inc. delivers specialized medical services for newborns, expectant mothers, and pediatric patients across the United States and Puerto Rico. The company offers crucial neonatal care to critically ill or prematurely born infants within hospital units, staffed by expert neonatal subspecialists and advanced practice clinicians. For pregnant individuals and their developing babies, Pediatrix provides comprehensive maternal-fetal medicine services in both clinical and inpatient settings, involving specialists such as maternal-fetal medicine physicians, obstetricians, and genetic counselors. Furthermore, the group delivers pediatric cardiology services, addressing both congenital and acquired heart conditions in patients ranging from the fetal stage through adulthood, under the care of dedicated pediatric cardiologists. Beyond these core areas, Pediatrix extends its expertise to various other pediatric subspecialties, including those requiring intensivists, surgeons, and ophthalmologists, and supplies vital support to hospital departments like emergency rooms and labor and delivery units. Established in 1979 in Sunrise, Florida, and formerly known as MEDNAX, Inc. until its renaming in July 2022, the company managed a network of approximately 2,700 physicians as of February 2022.
CEO: Mark S. Ordan. Company website
MD — Frequently Asked Questions
What is the MD stock price today?
Pediatrix Medical Group, Inc. (MD) trades at $31.45, down 0.54% on the day, as of Nov 12, 2026 09:30 UTC.
What is Pediatrix Medical Group, Inc.'s market cap?
Pediatrix Medical Group, Inc. has a market capitalisation of $2.46B, calculated from the live MD share price and shares outstanding.
What is the P/E ratio of MD?
MD trades at a trailing P/E of 17.13, from earnings per share of $1.84 over the last twelve months.
How much revenue does Pediatrix Medical Group, Inc. make?
Pediatrix Medical Group, Inc. generated revenue of $1.96B over the trailing twelve months, which puts the stock at 1.25 times sales.
What is the 52-week range for MD?
MD has traded between $17.23 and $33.74 over the past 52 weeks, and the last price is 6.8% below that high.
Is Pediatrix Medical Group, Inc. profitable?
Yes. Pediatrix Medical Group, Inc. keeps 7.66% of revenue as net income over the trailing twelve months.
What is the analyst price target for MD?
Wall Street analysts rate MD Hold, with an average price target of $27.25, 13.4% below the current price.
What sector is Pediatrix Medical Group, Inc. in?
Pediatrix Medical Group, Inc. is classified under the Healthcare sector and the Medical - Care Facilities industry, and is domiciled in US.
Who is the CEO of Pediatrix Medical Group, Inc.?
Mark S. Ordan is the chief executive of Pediatrix Medical Group, Inc., which employs 4,280 people.
Where can I track MD in real time?
QFI Terminal shows MD with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
See MD live in QFI Terminal
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open MD in Terminal See plans